Vertex Pharmaceuticals

Filed a patent for "cell therapy for diabetes" on Fri, July 28, 2023

Filed a patent for "macroencapsulation device implantation and transport system and methods" on Fri, July 21, 2023

Filed a patent for "macroencapsulation devices including immunomodulatory compounds" on Tue, February 14, 2023

Filed a patent for "compact proteins" on Fri, May 12, 2023

Filed a patent for "methods for directing lipid nanoparticles in vivo" on Fri, May 26, 2023

Filed a patent for "affinity purification methods for adeno associated viruses (aavs)" on Wed, May 31, 2023

Filed a patent for "stem cell derived pancreatic islet differentiation" on Thu, November 21, 2024

Filed a patent for "gene editing of regulatory elements" on Thu, October 17, 2024

Filed a patent for "enhanced differentiation of beta cells" on Thu, June 29, 2023

Filed a patent for "hypoimmune cells" on Thu, August 22, 2024

Filed a patent for "n-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamide analogs as modulators of sodium channels" on Fri, December 1, 2023

Filed a patent for "precise excisions of portions of exon 51 for treatment of duchenne muscular dystrophy" on Thu, August 1, 2024

Filed a patent for "re-aggregation of stem cell-derived pancreatic beta cells" on Thu, July 18, 2024

Filed a patent for "substituted tetrahydrofuran-2-carboxamides as modulators of sodium channels" on Fri, December 1, 2023

Filed a patent for "macroencapsulation devices" on Fri, February 9, 2024

Filed a patent for "compounds useful as inhibitors of atr kinase" on Thu, August 31, 2023

Filed a patent for "materials and methods for treatment of myotonic dystrophy type 1 (dm) and other related disorders" on Thu, July 20, 2023

Filed a patent for "modulators of cystic fibrosis transmembrane conductance regulator" on Thu, July 27, 2023

Filed a patent for "tandem guide rnas (tg-rnas) and their use in genome editing" on Mon, July 18, 2022

Filed a patent for "modulators of cystic fibrosis transmembrane conductance regulator" on Fri, July 29, 2022

Filed a patent for "compositions for the treatment of cftr-mediated diseases" on Thu, August 4, 2022

Filed a patent for "modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator" on Thu, November 9, 2023

Filed a patent for "method for treating cancer using a combination of dna damaging agents and atr inhibitors" on Thu, April 6, 2023

Filed a patent for "methods of treatment for cystic fibrosis" on Thu, August 3, 2023

Filed a patent for "precise excisions of portions of exon 44, 50, and 53 for treatment of duchenne muscular dystrophy" on Wed, September 7, 2022